Questcor Pharmaceuticals (QCOR) Jumps Higher on Analyst Defense
Tweet Send to a FriendGet Alerts QCOR Hot Sheet
Price: $37.34 +1.30%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 2.9%
EPS Growth %: +24.6%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 2.9%
EPS Growth %: +24.6%
Trade QCOR Now!
Questcor Pharmaceuticals (Nasdaq: QCOR) is bouncing again on word analysts at BofA have confirmed that the company threatening to develop a generic form of ACTH is fraudulent.
While still down 3.4 percent, these comments are moving shares higher - something the earlier company JMP presentation was unable to do.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
While still down 3.4 percent, these comments are moving shares higher - something the earlier company JMP presentation was unable to do.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Vanda Pharmaceuticals (VNDA) Opens Higher; Lazard Raises PT to $17
- Berkshire Hathaway (BRK-A) Cut to 'AA' From 'AA+' by S&P
- Amarin's (AMRN) Vascepa Not in FDA Orange Book for April
Create E-mail Alert Related Categories
Trader TalkRelated Entities
Bank of AmericaLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

